Ion-exchange membranes (IEMs) find more and more applications; the success of an application depends on the properties of the membranes selected for its realization. For the first time, the results of a comprehensive characterization of the transport properties of IEMs from three manufactures (Astom, Japan; Shchekinoazot, Russia; and Fujifilm, The Netherlands) are reported. Our own and literature data are presented and analyzed using the microheterogeneous model. Homogeneous Neosepta AMX and CMX (Astom), heterogeneous MA-41 and MK-40 (Shchekinoazot), and AEM Type-I, AEM Type-II, AEM Type-X, as well as CEM Type-I, CEM Type-II, and CEM Type-X produced by the electrospinning method (Fujifim) were studied. The concentration dependencies of the conductivity, diffusion permeability, as well as the real and apparent ion transport numbers in these membranes were measured. The counterion transport number characterizing the membrane permselectivity increases in the following order: CEM Type-I MA-41 < AEM Type-I < MK-40<CMX CEM Type-II CEM Type-X AEM Type-II < AMX < AEM Type-X. It is shown that the properties of the AEM Type-I and CEM Type-I membranes are close to those of the heterogeneous MA-41 and MK-40 membranes, while the properties of Fujifilm Type-II and Type-X membranes are close to those of the homogeneous AMX and CMX membranes. This difference is related to the fact that the Type-I membranes have a relatively high parameter f2, the volume fraction of the electroneutral solution filling the intergel spaces. This high value is apparently due to the open-ended pores, formed by the reinforcing fabric filaments of the Type-I membranes, which protrude above the surface of these membranes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.